MedPath

Pain management in elderly hip fractures

Phase 4
Not yet recruiting
Conditions
Fracture of head and neck of femur, (2) ICD-10 Condition: S721||Pertrochanteric fracture,
Registration Number
CTRI/2022/11/047757
Lead Sponsor
Ganga Medical Centre and Hospitals Pvt Ltd
Brief Summary

The study proposes to include patients aged more than 65 years identified to have either intertrochanteric fracture or neck of femur fracture. They will be initially checked if they meet the inclusion criteria and upon that will be included in the study. They will be divided into two groups either Femoral nerve group or Pericapsular nerve group block according to Computer generated randomization. They will undergo block administration on arrival according to their group. Their pain assessment (according to VAS scale) and vitals monitoring would be done at regular intervals. They will undergo surgical management for the fracture. They will receive block again in the preoperative period according to the earlier decided group. Their pain assessment, vitals monitoring and muscle strength would be done at regular intervals. Other complications such as post-operative onset delirium would be assessed. Finally total opioid administration during their stay, and duration of hospital stay would be assessed. Results will be analyzed to know whether Femoral nerve block is better than the Pericapsular nerve group block as preemptive analgesia in Geriatric hip fracture patients. This would help us to better understand the role of the block as preemptive analgesia in Geriatric hip fracture patients

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients with Neck of femur and intertrochanteric fracture above 65 years of age will be included in the study.

Exclusion Criteria

Patients with polytrauma, open fractures, fractures with subtrochanteric extension, non-ambulatory patients, unable to communicate, patients having history of opioid abuse, patients currently on opioid medication and patients who do not consent for the study will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of reduction in pain would be done using VAS scoring, opioid use will be calculated in terms of milliequivalents of morphine, muscle strength will be calculated according to MRC grading, duration of hospital stay will be calculated and compared between participants receiving Femoral nerve block and Pericapsular nerve group blockAssessment to be done till discharge of patient from hospital
Secondary Outcome Measures
NameTimeMethod
Blood loss during surgery, Ease of positioning patient during surgery, Incidence of Delirium in post operative period will be assessedAssessment of reduction in pain would be Assessment to be done till discharge of patient from hospital

Trial Locations

Locations (1)

Ganga Medical Centre and Hospitals Pvt. Ltd

🇮🇳

Coimbatore, TAMIL NADU, India

Ganga Medical Centre and Hospitals Pvt. Ltd
🇮🇳Coimbatore, TAMIL NADU, India
Dr S Rajasekharan
Principal investigator
9843022325
rajasekaran.orth@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.